You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 119 No. 2, February 1984 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE THIRD ANNUAL MEETING OF THE SURGICAL INFECTION SOCIETY, FORT LAUDERDALE, FLA, MAY 7-10, 1983-PART II
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (45)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Role of Prostacyclin and Thromboxane in Sepsis and Septic Shock

Richard H. Carmona, MD; Tanny C. Tsao, MS; Donald D. Trunkey, MD

Arch Surg. 1984;119(2):189-192.


Abstract

• Prostacyclin, or prostaglandin I2 (PGI2), and thromboxane A2 (TXA2) are potent, endogenously produced, vasoactive substances that have been implicated as mediators in the pathophysiologic nature of septic shock. We investigated the contribution and production of PGI2 and TXA2 in sepsis and septic shock, using an intact rabbit model and an in vitro rabbit isolated cardiac perfusion model. Continuous hemodynamic monitoring of both experimental models, along with serial radioimmunoassays of the metabolites of PGI2 and TXA2, indicated that myocardial depression is a common finding in subjects with septic shock and that septic shock causes a suppression of PGI2 production while augmenting TXA2 production. In addition, PGI2 and TXA2 were mediators of some cardiovascular changes in septic shock but were themselves not the toxic factor(s) responsible for the associated myocardial depression.

(Arch Surg 1984;119:189-192)



Author Affiliations

From the University of California—San Francisco Medical School and the Department of Surgery, San Francisco General Hospital.


Footnotes

Accepted for publication Sept 16, 1983.

Read before the Third Annual Meeting of the Surgical Infection Society, Fort Lauderdale, Fla, May 10, 1983.

Reprint requests to Surgical Service, San Francisco General Hospital, San Francisco, CA 94110 (Dr Trunkey).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Role of Thromboxane in Producing Hepatic Injury During Hepatic Stress
Yokoyama et al.
Arch Surg 2005;140:801-807.
ABSTRACT | FULL TEXT  

Thromboxane A2-Receptor Blockade and Prostacyclin in Porcine Escherichia coli Shock
Svartholm et al.
Arch Surg 1989;124:669-672.
ABSTRACT  

Myocardial Dysfunction in Septic Shock
Carmona et al.
Arch Surg 1985;120:30-35.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.